| P50 | author | Rachel Kubiak | Q55523656 |
| | Charles Robert Horsburgh | Q42864243 |
| P2093 | author name string | Timothy Heeren | |
| | David Nunes | |
| | Deborah Cotton | |
| | Amy S Baranoski | |
| P2860 | cites work | Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis | Q45763095 |
| | Prognosis of chronic hepatitis C: results of a large, prospective cohort study. | Q50856021 |
| | Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients. | Q50871419 |
| | Mortality for Liver Disease in Patients With HIV Infection: A Cohort Study | Q60216395 |
| | Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy | Q80551551 |
| | Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease | Q81572742 |
| | Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II | Q28260514 |
| | Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups | Q29614459 |
| | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 |
| | The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 |
| | The risk of long-term morbidity and mortality in patients with chronic hepatitis C: results from an analysis of data from a Department of Veterans Affairs Clinical Registry | Q30689293 |
| | Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection | Q32127288 |
| | Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection | Q33533738 |
| | The natural history of hepatitis C virus infection: host, viral, and environmental factors | Q33974693 |
| | CD4 recovery on antiretroviral therapy is associated with decreased progression to liver disease among hepatitis C virus-infected injecting drug users | Q35628281 |
| | Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women | Q36230189 |
| | Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV | Q37252421 |
| | Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans | Q37579940 |
| | Hepatitis C virus infection in USA: an estimate of true prevalence | Q37899936 |
| | Hepatitis C virus load and survival among injection drug users in the United States | Q42996922 |
| | The natural history of hepatitis C infection acquired through injection drug use: meta-analysis and meta-regression. | Q42997586 |
| | Immunological status does not influence hepatitis c virus or liver fibrosis in HIV-hepatitis C virus-coinfected patients | Q43000875 |
| | Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study | Q43035030 |
| | The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. | Q43035585 |
| | Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group | Q43036483 |
| | Gender differences in liver fibrosis and hepatitis C virus-related parameters in patients coinfected with human immunodeficiency virus | Q43039570 |
| | Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. | Q43039596 |
| | Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients | Q43225349 |
| | Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. | Q43659671 |
| | Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy | Q43693273 |
| | Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study | Q44696144 |
| | Studies of the reliability and validity of the Addiction Severity Index | Q44818402 |
| | Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection | Q44920531 |
| | HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). | Q44933768 |
| | Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients. | Q45381381 |
| | Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis | Q45736423 |
| | Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection | Q45738786 |
| | Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group | Q45747079 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | ofv214 | |
| P577 | publication date | 2015-12-31 | |
| P1433 | published in | Open Forum Infectious Diseases | Q27725953 |
| P1476 | title | Clinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm(3) Is More Pronounced Among Women Than Men | |
| P478 | volume | 3 | |